Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group.

Verweij, J; Lee, S M; Ruka, W; Buesa, J; Coleman, R; van Hoessel, R; Seynaeve, C; di Paola, E D; van Glabbeke, M; Tonelli, D; Judson, I R

Verweij, J; Lee, S M; Ruka, W; Buesa, J; Coleman, R; van Hoessel, R; Seynaeve, C; di Paola, E D; van Glabbeke, M; Tonelli, D; Judson, I R.

Affiliation

Verweij J; Department of Medical Oncology, Rotterdam Cancer Institute, and University Hospital Rotterdam, Nijmegen, the Netherlands.

J Clin Oncol ; 18(10): 2081-6, 2000 May.

Article in En | MEDLINE | ID: mdl-10811673

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Soft Tissue Neoplasms / Doxorubicin / Paclitaxel / Taxoids / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Oncol Year: 2000 Document type: Article Affiliation country: Países Bajos

Search on Google

Add to My VHL

XML

PubMed Links